ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,826,405 | -71.3% | 3,715 | -77.2% | 1.66% | -53.0% |
| Q2 2023 | $6,358,445 | -28.9% | 16,315 | -32.0% | 3.52% | -4.9% |
| Q1 2023 | $8,941,920 | -1.6% | 24,000 | 0.0% | 3.71% | +8.5% |
| Q4 2022 | $9,091,920 | +7.3% | 24,000 | 0.0% | 3.42% | +11.8% |
| Q3 2022 | $8,473,000 | -6.8% | 24,000 | 0.0% | 3.05% | -1.6% |
| Q2 2022 | $9,093,000 | +20.2% | 24,000 | 0.0% | 3.10% | +179.0% |
| Q1 2022 | $7,567,000 | -2.7% | 24,000 | +8.1% | 1.11% | +26.1% |
| Q4 2021 | $7,774,000 | +16.0% | 22,200 | 0.0% | 0.88% | -27.6% |
| Q3 2021 | $6,704,000 | +5.0% | 22,200 | +4.7% | 1.22% | -26.6% |
| Q2 2021 | $6,383,000 | +9.3% | 21,200 | 0.0% | 1.66% | +57.3% |
| Q1 2021 | $5,838,000 | +56.3% | 21,200 | +66.9% | 1.06% | +36.0% |
| Q4 2020 | $3,735,000 | +89.7% | 12,700 | +69.3% | 0.78% | +273.1% |
| Q3 2020 | $1,969,000 | -75.6% | 7,500 | -79.1% | 0.21% | -87.2% |
| Q2 2020 | $8,063,000 | +83.2% | 35,800 | -21.8% | 1.63% | -23.7% |
| Q4 2018 | $4,401,000 | – | 45,806 | – | 2.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |